论文部分内容阅读
肝复康治疗家兔血吸虫病肝纤维化试验的结果表明,该药能明显改善家兔肝纤维化病变。经肝复康治疗后,肝脏的胶原纤维量为15.4mg/g 肝;胶原纤维厚度为171.3μm;胶原纤维面积为4.61％。而对照组肝脏的胶原纤维量为29.0mg/g 肝;胶原纤维厚度为478.1μm;胶原纤维面积为14.4％。两组之间均有显著性差异(P<0.05)。病理组织学发现,肝复康治疗后,肝损伤可从Ⅲ级改善为Ⅰ级。动物实验证明,该药为治疗血吸虫病肝硬化的理想药物。
Liver rehabilitation treatment of rabbit schistosomiasis liver fibrosis test results show that the drug can significantly improve the rabbit liver fibrosis. After liver rehabilitation treatment, the amount of liver collagen fibers was 15.4mg / g liver; collagen fiber thickness of 171.3μm; collagen fiber area of 4.61%. While the amount of collagen fibers in the liver of the control group was 29.0 mg / g liver; the collagen fiber thickness was 478.1 μm; and the collagen fiber area was 14.4%. There was a significant difference between the two groups (P <0.05). Histopathology found that after liver rehabilitation, liver injury can be improved from grade Ⅲ to grade Ⅰ. Animal experiments show that the drug for the treatment of schistosomiasis cirrhosis of the ideal drug.